The NeuraMetrix Blog

March 13, 2019

FDA Grants Breakthrough Device Designation to NeuraMetrix

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the NeuraMetrix brain health monitoring solution. The designation is granted for devices “that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating human disease or conditions”.

​​​​​​​Read More

March 13, 2019

SharpBrains Virtual Summit 2019

10+ Pioneers, Including Neurametrix' CEO Jan Samzelius, Confirmed to Speak at The 2019 Sharpbrains Virtual Summit: The Future of Brain Health on May 7th Through the 9th, 2019.

Read More